Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.
Jing Ma(Qinghai Normal University), David J. Hunter(The University of Sydney), Peter H. Gann(University of Illinois Chicago), Edward L. Giovannucci(Massachusetts Department of Public Health), Karl T. Kelsey(Brown University), Charles H. Hennekens(Florida Atlantic University), M. J. Stampfer(Brigham and Women's Hospital), Heather Hough
PubMed
May 1, 1998
Cited by 214
Related Papers
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
REPRODUCIBILITY AND VALIDITY OF A SEMIQUANTITATIVE FOOD FREQUENCY QUESTIONNAIRE
|American Journal of Epidemiology|1985|4.3k
Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality—a systematic review and dose-response meta-analysis of prospective studies
|International Journal of Epidemiology|2016|2.5k
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes
|American Journal of Clinical Nutrition|2006|2.4k
Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular Disease
|New England Journal of Medicine|1996|2.4k